(INNS)
TAGITANLIMAB(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS CD274 (PROGRAMMED CELL DEATH 1 LIGAND 1, B7H1, B7-H1, PDL1, PD-L1, PDCD1L1, B7 HOMOLOG 1)], HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HUMANIZED (1-450) [VH (HOMO SAPIENS IGHV4-4*08 (81.4%) -(IGHD) -IGHJ4*01 (92.9%), CDR-IMGT [8.7.14] (26-33.51-57.96-109)) (1- 120) -HOMO SAPIENS IGHG1*01, G1M17,1, G1V14 CH2 A1.3, A1.2 (CH1 K120 (217) (121-218), HINGE 1-15 (219-233), CH2 L1.3>A (237), L1.2>A (238), G1>A (240) (234-343), CH3 D12 (359), L14 (361) (344-448), CHS (449-450)) (121-450)], (223-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') [V-KAPPA (HOMO SAPIENS IGKV6-21*02 (86.3%) -IGKJ2*01 (100%), CDR-IMGT [6.3.9] (27-32.50-52.89-97)) (1'- 107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')]; DIMER (229-229'':232- 232'')-BISDISULFIDE, PRODUCED IN A CHINESE HAMSTER OVARY (CHO)-DG44 CELL LINE, GLYCOFORM ALFA(WHO)
TAGITANLIMABUM(INN)